An emerging Biotech manufacturer wanted a stronger connection with the patient enrollment and adherence process of one of its major brands and needed assistance to assess and design a multi-generational strategy that worked in concert with strategies for the 4 P's: Prescriber, Payer, Pharmacy, Patient and the channels.
The Blue Fin Group objective on this engagement was to ensure the client had a) a solid plan of attack that factored internal and external issues and b) was completely manageable by the client after the Blue Fin Group finished its role. Our approach included a 360 degree assessment of the situation, collaborative design with the client’s sales and product executives, and a business plan with a clear blueprint and call to action.
Our final solution included a solid plan than grows with the client over 5 years, leveraging specialty pharmacy and services in a way that is very cost-effective and realistic to implement and manage.
As a firm specializing in connecting products with patients, Blue Fin Group was able to ask questions the client had not previously considered, and we unlocked a more comprehensive view of the interests of the touchpoints around the patient, and were therefore able to design very pragmatic solutions that were inclusive of the healthcare community yet afforded the client the ability to become an active participant in the treatment and satisfaction of the patient.
